Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2896365094', 'doi': 'https://doi.org/10.1002/cpdd.614', 'title': 'Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects', 'display_name': 'Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects', 'publication_year': 2018, 'publication_date': '2018-10-10', 'ids': {'openalex': 'https://openalex.org/W2896365094', 'doi': 'https://doi.org/10.1002/cpdd.614', 'mag': '2896365094', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30303626'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/cpdd.614', 'pdf_url': 'https://accp1.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpdd.614', 'source': {'id': 'https://openalex.org/S2764863641', 'display_name': 'Clinical Pharmacology in Drug Development', 'issn_l': '2160-763X', 'issn': ['2160-763X', '2160-7648'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://accp1.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpdd.614', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5029238349', 'display_name': 'Hiroko Ino', 'orcid': 'https://orcid.org/0000-0002-6793-7944'}, 'institutions': [{'id': 'https://openalex.org/I4210115149', 'display_name': 'GlaxoSmithKline (Japan)', 'ror': 'https://ror.org/01j6sxy67', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210115149']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Hiroko Ino', 'raw_affiliation_strings': ['Medicines Development (Clinical Pharmacology Office), Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Medicines Development (Clinical Pharmacology Office), Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210115149']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033785127', 'display_name': 'Robert C. Wilson', 'orcid': 'https://orcid.org/0000-0002-2963-2971'}, 'institutions': [{'id': 'https://openalex.org/I188950975', 'display_name': 'GlaxoSmithKline (United Kingdom)', 'ror': 'https://ror.org/01xsqw823', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I188950975']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Robert Wilson', 'raw_affiliation_strings': ["Clinical Pharmacology Modelling and Simulation, Medicine's Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, UK"], 'affiliations': [{'raw_affiliation_string': "Clinical Pharmacology Modelling and Simulation, Medicine's Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, UK", 'institution_ids': ['https://openalex.org/I188950975']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069905143', 'display_name': 'Takumi Terao', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210115149', 'display_name': 'GlaxoSmithKline (Japan)', 'ror': 'https://ror.org/01j6sxy67', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210115149']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takumi Terao', 'raw_affiliation_strings': ['Biomedical Data Sciences Department, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Biomedical Data Sciences Department, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210115149']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053078432', 'display_name': 'Hirofumi Ogura', 'orcid': 'https://orcid.org/0000-0002-8042-6495'}, 'institutions': [{'id': 'https://openalex.org/I4210115149', 'display_name': 'GlaxoSmithKline (Japan)', 'ror': 'https://ror.org/01j6sxy67', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210115149']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hirofumi Ogura', 'raw_affiliation_strings': ['Medicines Development (Clinical Pharmacology Office), Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Medicines Development (Clinical Pharmacology Office), Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210115149']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035137765', 'display_name': 'Harue Igarashi', 'orcid': 'https://orcid.org/0000-0003-0423-128X'}, 'institutions': [{'id': 'https://openalex.org/I4210115149', 'display_name': 'GlaxoSmithKline (Japan)', 'ror': 'https://ror.org/01j6sxy67', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210115149']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Harue Igarashi', 'raw_affiliation_strings': ['Pre-Clinical Development, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Pre-Clinical Development, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210115149']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047225743', 'display_name': 'Anthony Cahn', 'orcid': 'https://orcid.org/0000-0002-7239-0461'}, 'institutions': [{'id': 'https://openalex.org/I188950975', 'display_name': 'GlaxoSmithKline (United Kingdom)', 'ror': 'https://ror.org/01xsqw823', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I188950975']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Anthony Cahn', 'raw_affiliation_strings': ['Pharma Research & Development, Respiratory TAU, GlaxoSmithKline, Stevenage, UK'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research & Development, Respiratory TAU, GlaxoSmithKline, Stevenage, UK', 'institution_ids': ['https://openalex.org/I188950975']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5035170485', 'display_name': 'Yotaro Numachi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210115149', 'display_name': 'GlaxoSmithKline (Japan)', 'ror': 'https://ror.org/01j6sxy67', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210115149']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yotaro Numachi', 'raw_affiliation_strings': ['Medicines Development, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Medicines Development, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210115149']}]}], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5029238349'], 'corresponding_institution_ids': ['https://openalex.org/I4210115149'], 'apc_list': {'value': 3450, 'currency': 'USD', 'value_usd': 3450, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.939, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 8, 'citation_normalized_percentile': {'value': 0.673719, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 84, 'max': 85}, 'biblio': {'volume': '8', 'issue': '1', 'first_page': '78', 'last_page': '86'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12369', 'display_name': 'Epidemiology and Pathogenesis of Pneumocystis Pneumonia', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12369', 'display_name': 'Epidemiology and Pathogenesis of Pneumocystis Pneumonia', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10038', 'display_name': 'Tuberculosis', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10554', 'display_name': 'Genetic and Clinical Aspects of Hemoglobin Disorders', 'score': 0.9944, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.8990295}, {'id': 'https://openalex.org/keywords/dry-powder-inhaler', 'display_name': 'Dry-powder inhaler', 'score': 0.58264315}, {'id': 'https://openalex.org/keywords/pharmacodynamics', 'display_name': 'Pharmacodynamics', 'score': 0.5117016}, {'id': 'https://openalex.org/keywords/treatment', 'display_name': 'Treatment', 'score': 0.471189}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.91502327}, {'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.8990295}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.76464903}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.6806164}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.6036674}, {'id': 'https://openalex.org/C2777419714', 'wikidata': 'https://www.wikidata.org/wiki/Q1334805', 'display_name': 'Dry-powder inhaler', 'level': 4, 'score': 0.58264315}, {'id': 'https://openalex.org/C2780261241', 'wikidata': 'https://www.wikidata.org/wiki/Q1394363', 'display_name': 'Inhaler', 'level': 3, 'score': 0.5793177}, {'id': 'https://openalex.org/C111113717', 'wikidata': 'https://www.wikidata.org/wiki/Q725307', 'display_name': 'Pharmacodynamics', 'level': 3, 'score': 0.5117016}, {'id': 'https://openalex.org/C2780333948', 'wikidata': 'https://www.wikidata.org/wiki/Q653305', 'display_name': 'Spirometry', 'level': 3, 'score': 0.47853073}, {'id': 'https://openalex.org/C76318530', 'wikidata': 'https://www.wikidata.org/wiki/Q16833590', 'display_name': 'Area under the curve', 'level': 2, 'score': 0.46395937}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.426118}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32870555}, {'id': 'https://openalex.org/C2776042228', 'wikidata': 'https://www.wikidata.org/wiki/Q35869', 'display_name': 'Asthma', 'level': 2, 'score': 0.09481418}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D010080', 'descriptor_name': 'Oxazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000280', 'descriptor_name': 'Administration, Inhalation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D044466', 'descriptor_name': 'Asians', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058995', 'descriptor_name': 'Dry Powder Inhalers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D064368', 'descriptor_name': 'Healthy Volunteers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010080', 'descriptor_name': 'Oxazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D010080', 'descriptor_name': 'Oxazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010080', 'descriptor_name': 'Oxazoles', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010080', 'descriptor_name': 'Oxazoles', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/cpdd.614', 'pdf_url': 'https://accp1.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpdd.614', 'source': {'id': 'https://openalex.org/S2764863641', 'display_name': 'Clinical Pharmacology in Drug Development', 'issn_l': '2160-763X', 'issn': ['2160-763X', '2160-7648'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30303626', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/cpdd.614', 'pdf_url': 'https://accp1.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpdd.614', 'source': {'id': 'https://openalex.org/S2764863641', 'display_name': 'Clinical Pharmacology in Drug Development', 'issn_l': '2160-763X', 'issn': ['2160-763X', '2160-7648'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.75, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [{'funder': 'https://openalex.org/F4320307773', 'funder_display_name': 'GlaxoSmithKline', 'award_id': None}], 'datasets': [], 'versions': [], 'referenced_works_count': 16, 'referenced_works': ['https://openalex.org/W1135839845', 'https://openalex.org/W2009461061', 'https://openalex.org/W2020022405', 'https://openalex.org/W2054972774', 'https://openalex.org/W2072349084', 'https://openalex.org/W2076588270', 'https://openalex.org/W2081550480', 'https://openalex.org/W2090018282', 'https://openalex.org/W2099449365', 'https://openalex.org/W2113558571', 'https://openalex.org/W2117984171', 'https://openalex.org/W2119767177', 'https://openalex.org/W2127951128', 'https://openalex.org/W2159739693', 'https://openalex.org/W2746637007', 'https://openalex.org/W2884986851'], 'related_works': ['https://openalex.org/W4389842934', 'https://openalex.org/W2904406609', 'https://openalex.org/W2540806743', 'https://openalex.org/W2219634259', 'https://openalex.org/W2204257390', 'https://openalex.org/W2185565026', 'https://openalex.org/W2138582447', 'https://openalex.org/W2095704965', 'https://openalex.org/W2056840755', 'https://openalex.org/W2037936952'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1, 60], 'aim': [2], 'of': [3, 14, 19, 56, 63, 97, 189], 'the': [4, 9, 82, 94, 133, 156, 180, 200], 'study': [5, 61], 'was': [6, 32, 148, 163, 197, 222], 'to': [7, 27, 50], 'assess': [8], 'safety,': [10], 'tolerability,': [11], 'and': [12, 16, 40, 84, 130, 155, 169, 182, 192, 199, 211, 217], 'pharmacokinetics': [13], 'single': [15], 'repeat': [17], 'doses': [18, 178, 188], 'nemiralisib': [20, 57], 'administered': [21], 'via': [22], 'a': [23, 33, 64, 67, 72, 77, 86], 'dry': [24], 'powder': [25], 'inhaler': [26], 'healthy': [28, 44], 'Japanese': [29, 45], 'subjects.': [30], 'This': [31], 'single‐center,': [34], 'double‐blind,': [35], 'randomized,': [36], 'placebo‐controlled,': [37], 'parallel,': [38], 'single‐': [39, 181], 'repeat‐ascending‐dose': [41], 'study.': [42], 'Thirty‐six': [43], 'male': [46], 'subjects': [47], 'were': [48, 104, 110, 215], 'randomized': [49], 'receive': [51], 'either': [52], '1': [53, 91], 'dose': [54, 96, 139], 'strength': [55], 'or': [58, 118, 177], 'placebo.': [59], 'consisted': [62], 'screening': [65], 'period,': [66], 'single‐dose': [68], 'session': [69, 74, 98], '(session': [70, 75, 202], '1),': [71], 'repeat‐dose': [73, 183], '2),': [76], '10‐day': [78], 'washout': [79], 'period': [80], 'between': [81, 175], 'sessions,': [83], 'then': [85], 'follow‐up': [87], 'visit': [88], '10': [89, 186], '±': [90], 'days': [92, 176], 'after': [93], 'last': [95], '2.': [99], 'No': [100, 106], 'serious': [101], 'adverse': [102], 'events': [103], 'reported.': [105], 'clinically': [107], 'significant': [108], 'abnormalities': [109], 'found': [111], 'in': [112, 140, 179], 'clinical': [113], 'laboratory': [114], 'results,': [115], 'vital': [116], 'signs,': [117], 'spirometry': [119], 'results.': [120], 'Generally,': [121], 'exposure': [122], '(maximum': [123], 'observed': [124, 230], 'plasma': [125, 231], 'concentration': [126, 233], '[C': [127], 'max': [128, 147, 168, 213], ']': [129], 'area': [131], 'under': [132], 'concentration‐time': [134], 'curve': [135], '[AUC])': [136], 'increased': [137], 'with': [138], 'an': [141], 'approximately': [142, 152, 164], 'proportional': [143], 'manner.': [144], 'Plasma': [145], 'T': [146, 167, 170], 'achieved': [149, 223], 'rapidly': [150], 'at': [151], '0.08': [153], 'hours,': [154], 'terminal': [157], 'elimination': [158], 'half‐life': [159], '(T': [160], '1/2': [161, 171], ')': [162, 210, 214, 236], '40': [165], 'hours.': [166], 'did': [172], 'not': [173], 'change': [174], 'sessions.': [184], 'Following': [185], 'daily': [187], '200,': [190], '500,': [191], '700': [193], 'μg': [194], 'nemiralisib,': [195], 'accumulation': [196], 'observed,': [198], 'ratios': [201], '2,': [203], 'day': [204], '10:session': [205], '1)': [206], 'for': [207], 'Ro(AUC': [208], '0‐24': [209], 'R(C': [212], '2.4‐3.0': [216], '1.5‐1.7,': [218], 'respectively.': [219], 'Steady': [220], 'state': [221], 'by': [224], '6‐7': [225], 'days,': [226], 'based': [227], 'on': [228], 'trough': [229, 235], 'drug': [232], '(C': [234], 'values.': [237]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2896365094', 'counts_by_year': [{'year': 2023, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 4}], 'updated_date': '2024-09-11T17:05:00.098259', 'created_date': '2018-10-26'}